HOWL: werewolftx.com Cash Calculated per Single Share

Werewolf Therapeutics, Inc. - graphic logo of issuer HOWL

Cash per share reflects the liquidity dynamics of Werewolf Therapeutics (HOWL), which is developing cancer immunotherapy through scientific alliances with pharma behemoths, while the value 0.85 shows the current magnitude of this metric. Business stability relies on independence from market cycles and GDP. Simultaneously, the company is implementing automated molecule screening to accelerate preclinical trials.

Werewolf Therapeutics Inc. (HOWL) - Cash per Share from 07/04/2022 to 11/20/2026

Comprehensive metric breakdowns and analytics for Werewolf (HOWL)

- current quotes and average value forecast:
- cash availability and cash flow indicators:
Comprehensive company analysis:Werewolf (HOWL)
Flagship merchandise of Werewolf Therapeutics Inc.

Werewolf Therapeutics (HOWL) develops precision oncology drugs that require significant R&D capital expenditures. The dynamics of highly liquid assets per share demonstrate the volume of available cash per security. This metric is calculated as the ratio of total liquid assets to the number of shares outstanding. Daily tracking allows for the identification of the cash burn rate prior to the publication of financial statements. A stable liquidity level confirms the financial stability of the biotech startup.